Breaking Research News from Breastcancer.org

Moderators

Two Types of Acupuncture Ease Pain Better Than Usual Care in Cancer Survivors
March 25, 2021
Two types of acupuncture were better than physical therapy, steroids, and pain medicine usually used to ease ongoing muscle and/or joint pain among cancer survivors. Read more...

Moderators

Two Types of Acupuncture Ease Pain Better Than Usual Care in Cancer Survivors
March 25, 2021
Two types of acupuncture were better than physical therapy, steroids, and pain medicine usually used to ease ongoing muscle and/or joint pain among cancer survivors. Read more...

Moderators

U.S. Screening Mammogram Rates Rebounding After Pandemic Drop, but Still Low for Certain Groups
April 6, 2021
After coming to a halt at the beginning of the pandemic, numbers of screening mammograms are climbing back up to nearly pre-pandemic levels, but rates among Hispanic and Asian women continue to be lower than average. Read more...

Moderators

For Women First Diagnosed With Breast Cancer, Risk of Second Cancer Goes Up as Weight Increases
April 13, 2021
If a woman has been diagnosed with breast cancer, her risk of being diagnosed with a second primary cancer increases as her weight increases. Read more...

Moderators

3D Screening Mammograms Reduce Interval Breast Cancer Rate Compared to 2D Digital Mammograms
April 15, 2021
A Swedish study found 3D screening mammograms reduce the rate of interval cancers — cancers detected in between routine screening — compared to 2D digital mammograms. Read more...

Moderators

Some Triple-Negative Breast Cancers Are More Aggressive Than Others
April 22, 2021
Not all triple-negative breast cancers are the same, with certain subtypes being more aggressive than others, according to a study. Read more...

Moderators

Reducing Treatment Seems Safe for Older Women With Early-Stage, Hormone-Receptor-Positive Breast Cancer
May 4, 2021
Skipping sentinel lymph node biopsy and/or radiation therapy didn't affect recurrence rates or survival for women age 70 and older diagnosed with early-stage, hormone-receptor-positive, HER2-negative, clinically node-negative breast cancer. Read more...

Moderators

Women at High Risk for Breast Cancer Face Financial Barriers to Preventive Care, Even With Insurance
May 11, 2021
Women with a higher-than-average risk of breast cancer face barriers to preventive care because of financial concerns, even when they have health insurance. Read more...

Moderators

People Taking Hormonal Therapy for Breast Cancer Have Higher Risk of Heart Disease, Monitoring Recommended
May 11, 2021
People taking hormonal therapy medicine to treat breast or prostate cancer have a higher risk of heart attack and stroke as they get older and should be monitored regularly to detect any problems. Read more...

Moderators

Lumpectomy Plus Radiation Offers Better Survival Rates Than Mastectomy for Early-Stage Breast Cancer
May 18, 2021
Lumpectomy plus radiation therapy offers better survival rates than mastectomy — with or without radiation — for women who are diagnosed with early-stage breast cancer. Read more...

Moderators

After Breast Cancer Treatment, Personalized Survivorship Care Needed
May 18, 2021
Survivorship care plans need to be personalized to meet breast cancer survivors' differing needs. Read more...

Moderators

Some Breast Cancers May Switch HER2 Status if They Come Back
May 18, 2021
If breast cancer comes back — called recurrence by doctors — the HER2 status of the recurrent cancer may change from HER2-positive or HER2-negative to a new classification of HER2 status, called HER2-low. Read more...

Moderators

Fertility Concerns May Make Young Women Skip or Delay Hormonal Therapy After Breast Cancer Surgery
May 18, 2021
Younger women diagnosed with hormone-receptor-positive breast cancer may skip or delay taking hormonal therapy medicine after surgery because they're concerned about having children. Read more...

Moderators

Triple-Negative Breast Cancer Deadlier for Black Women, Partially Due to Lower Surgery, Chemotherapy Rates
May 18, 2021
Black women who are diagnosed with triple-negative breast cancer are 28% more likely to die from the disease than white women with the same diagnosis. Read more...

Moderators

Timely Surveillance Mammograms Less Likely for Minority Breast Cancer Survivors
May 20, 2021
Black and Hispanic breast cancer survivors are less likely to receive timely surveillance mammograms compared with white women. Read more...

Moderators

Loneliness, Anxiety Felt by Many People With Cancer During COVID-19 Pandemic
May 21, 2021
More than half of people who have been diagnosed with cancer feel lonely, most likely as a result of social distancing and isolation during the COVID-19 pandemic. Read more...

Moderators

Multiple Sclerosis Doesn't Seem To Affect Breast Cancer Survival
May 24, 2021
Women diagnosed with MS and breast cancer have about the same risk of dying from breast cancer as women diagnosed with only breast cancer, but women with MS and breast cancer are more likely to die from any cause than women diagnosed with only breast cancer. Read more...

Moderators

Women of Color, Rural Women More Likely to Miss Breast Cancer Screening During Pandemic
June 2, 2021
Women of color and women living in rural areas were more likely to miss regular screening mammograms during the COVID-19 pandemic than white and urban women. Read more...

Moderators

People Receiving Cancer Treatment Develop 'Adequate' Immune Response to Pfizer COVID-19 Vaccine
June 4, 2021
Nearly all the people in a clinical trial who were receiving systemic intravenous cancer treatment had an adequate immune response to the Pfizer-BioNTech COVID-19 vaccine. Read more...

Moderators

Untangling Link Between Hair Relaxers and Breast Cancer Risk in Black Women
June 8, 2021
There seems to be no link between hair relaxers and breast cancer risk in Black women. But researchers found some evidence suggesting that heavy use of hair relaxers containing lye may be linked to a higher risk of estrogen-receptor-positive breast cancer. Read more...

Moderators

Do Black Women Diagnosed With Breast Cancer Have Higher Rates of Genetic Mutations Than White Women?
June 8, 2021
Black women and white women diagnosed with breast cancer have about the same rates of genetic mutations linked to a higher risk of breast cancer. Read more...

Moderators

Lynparza Offers Benefits for Early-Stage HER2-Negative Breast Cancer With BRCA1/2 Mutation
June 10, 2021
Adding Lynparza to standard treatment for early-stage HER2-negative breast cancer with a high risk of recurrence in people with a BRCA1 or BRCA2 mutation improved disease-free survival. Read more...

Moderators

Ibrance-Faslodex Combo Continues To Improve Overall Survival in Advanced-Stage, Hormone-Receptor-Positive Breast Cancer
June 10, 2021
The latest results from the PALOMA-3 trial show that combining Ibrance and Faslodex continues to offer better overall survival than Faslodex alone. Read more...

Moderators

Kisqali-Faslodex Combo Continues To Improve Overall Survival in Advanced-Stage, Hormone-Receptor-Positive Breast Cancer in Postmenopausal Women
June 20, 2021
The latest results from the MONALEESA-3 study show that combining Kisqali plus Faslodex continues to offer better overall survival than Faslodex alone. Read more...

Moderators

People With Active Cancer Hospitalized for COVID-19 More Likely To Die
June 15, 2021
When hospitalized for COVID-19, people receiving cancer treatment had a higher risk of dying than people with a history of cancer or people who had never been diagnosed with cancer. Read more...

Moderators

Adding Tukysa to Standard of Care Continues To Improve Survival in Advanced-Stage HER2-Positive Breast Cancer
June 15, 2021
Adding Tukysa to the standard of care of Herceptin and Xeloda continued to improve both progression-free and overall survival in people diagnosed with either metastatic or unresectable locally advanced HER2-positive breast cancer that had been previously treated with Herceptin, Perjeta, and Kadcyla. Read more...

Moderators

Most Women With Metastatic Breast Cancer Have Troubling Treatment Side Effects, Willing To Discuss Dosing Options With Doctor
June 16, 2021
About 86% of women diagnosed with metastatic breast cancer had at least one bad treatment-related side effect, and 92% were willing to discuss options for different dosing levels of medicines based on their unique situations. Read more...

Moderators

Preventively Removing Fallopian Tubes First, Ovaries Later Offers Better Quality of Life for Women With BRCA Mutations
June 23, 2021
Women with a BRCA1 or BRCA2 gene mutation had better menopause-related quality of life after having surgery to remove the fallopian tubes between ages 40 and 50, and then surgery to remove the ovaries much later, than women who had both the fallopian tubes and ovaries removed when they were in their 40s. Read more...

Moderators

Why Are Women in Mexico Who Are Diagnosed With Breast Cancer Avoiding COVID-19 Vaccines?
June 29, 2021
In Mexico, a group of women diagnosed with breast cancer were reluctant to get a COVID-19 vaccine because they were afraid of side effects and didn't trust their healthcare system. Read more...

Moderators

Ultralow MammaPrint Score Means Excellent Breast Cancer Outcomes
June 29, 2021
People diagnosed with breast cancer who got an ultralow risk of recurrence score on the MammaPrint genomic test had excellent long-term outcomes, whether or not they received hormonal therapy and/or chemotherapy after surgery. Read more...